Labcorp Holdings (LH) Q1 2025 Earnings Call April 29, 2025 09:00 AM ET Company Participants Christin O'donnell - VP - Investor RelationsAdam Schechter - President, CEO & ChairmanJulia Wang - EVP & CFOLisa Gill - Managing DirectorKevin Caliendo - Managing DirectorMichael Ryskin - Managing DirectorPatrick Donnelly - Managing Director Conference Call Participants Michael Cherny - Senior Managing Director & Senior Research AnalystAnn Hynes - Senior Healthcare Services Equity Analyst & Managing DirectorErin Wrig ...

Updates Full-Year Guidance Results from Operations for first quarter 2025 versus first quarter last year: Revenue: $3.35 billion versus $3.18 billion Diluted EPS: $2.52 versus $2.69 Adjusted EPS: $3.84 versus $3.68 Reaffirmed Revenue and Free Cash Flow guidance, raised midpoint of adjusted EPS: Revenue guidance of 6.7% to 8.0% Adjusted EPS range of $15.70 to $16.40; midpoint raised $0.05 Free Cash Flow of $1.10 billion to $1.25 billion Providing broader access to comprehensive testing and laboratory ser ...

Labcorp Holdings, Inc. (LH) has announced the nationwide launch of an FDA-approved human papillomavirus (HPV) self-collection solution that can help women and their physicians assess the risk of developing cervical cancer. Additionally, the company will offer a vaginal swab self-collect option for sexually transmitted infection (STI) testing.Both solutions require a physician’s order and can be completed privately in a healthcare setting or at any one of Labcorp's 2,200 Patient Service Centers (PSCs) nation ...

New offering expands screening options for cervical cancer and sexually transmitted infections (STIs), including chlamydia, gonorrhea, trichomonas or mycoplasma genitalium (Mgen) BURLINGTON, N.C., April 1, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer nationwide a U.S. Food and Drug Administration (FDA) approved human papillomavirus (HPV) self-collection solution that can help women and their physicians asses the r ...